.png){kind=icon}
Preclinical Oncology Posters
- A comparative evaluation of immunotherapy responses in murine colon carcinoma
- Anti-mCTLA-4 treatment results in early and late immune response effects in a murine model of colorectal carcinoma
- Characterization of proliferation in multiple lymphocyte subsets in the CT26 murine colon carcinoma model by multi-color flow cytometry
- Combination of a glycomimetic antagonist to E-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T Cell infiltration and accelerates time to complete response in the murine CT26 tumor model
- Combination of rapamycin with immune checkpoint blockade in a syngeneic breast carcinoma model
- Combined dynamic 18F-FDG PET imaging and DCE prediction of treatment response in an orthotopic model of glioblastoma multiforme
- Combined focal radiation and anti-mCTLA-4 antibody therapy modulates myeloid subset phospho-stat3 levels in the 4T1 tumor microenvironment, and results in tumor growth inhibition
- Comprehensive 10-color flow cytometry analysis of the neuroblastoma intratumoral immune response using the murine syngeneic Neuro-2a tumor model
- Evaluation of immunomodulatory agents in classically immunologically “cold” cancers using syngeneic mouse models of breast and ovarian cancer
- Evaluation of the immune response following treatment with anti‐CTLA‐4 antibody, radiation therapy or the combination in a murine model of breast cancer
- Focal radiation enhances paclitaxel therapy in a mouse model of triple negative breast cancer
- High-throughput analysis of MAPK and JAK-STAT signaling in CT26 tumors using a combination of immunophenotyping and phospho-flow cytometry
- ID8-Luc syngeneic ovarian cancer model for preclinical evaluation of immunomodulatory molecules
- Image-guided focal irradiation in syngeneic preclinical oncology mouse models
- Imaging the future | Published in the European Biopharmaceutical Review
- In-depth myeloid cell characterization in the murine syngeneic CT.26 colon carcinoma model by 10-color flow cytometry
- Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
- Preclinical models of multiple myeloma
- Preclinical response of murine syngeneic tumor models to immune checkpoint inhibitor antibodies
- Preclinical use of focal radiation and immune checkpoint blockade to improve therapeutic response in an immunologically cold tumor
- Radiation enhances anti-tumor activity of checkpoint blockade in syngeneic tumor models
- Radiation response in preclinical orthotopic models of brain cancer
- Sensitivity of syngeneic tumor models to focal radiation
- Systemic and subcutaneous modeling of A20 murine B cell lymphoma in mice: A comparative assessment
- TIGIT directed human antibody modulates T-regulatory and effector cell function